PrizValve® Transcatheter Aortic Valve Replacement Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.
Also called NCT04836897
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Registry
-
NCT04836897
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04836897. Allocation not applicable; no masking; primary purpose treatment. Start 2021-01-19 (actual); primary completion 2023-06-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PrizValve® Transcatheter Aortic Valve Replacement Study
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- PrizValve® valve and transapical delivery system
- Lead sponsor
- Shanghai NewMed Medical Co., Ltd.
Record details
- Record id
cardio:ct-nct04836897- Content hash
049752905b73c723e1770e498c965d1bd0bca5538cd237abed499423522a8807